LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Limited (“Tenpoint”) and Visus Therapeutics, Inc., (“Visus”) announce today the completion of their ...
Tenpoint Therapeutics, Inc., a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye, today reported positive topline results from BRIO- ...
Two new flagship models—the TenPoint TRX26 and Ravin LR—are priced over the $2000 mark. These crossbows showcase the latest technologies with lightweight designs and impressive speeds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results